Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders

Age and Ageing

Volumn 37, Issue 2, 2008, Pages 207-213

  Akerblom, Jennifer L ^a   Costa, Rosann ^b   Luchsinger, Jose A ^b   Manly, Jennifer J ^a,b   Tang, Ming Xin ^a,b   Lee, Joseph H ^a,b   Mayeux, Richard ^a,b   Schupf, Nicole ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

Author keywords

Ageing; All cause mortality; Elderly; Plasma lipids; Race ethnicity

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AFRICAN AMERICAN; AGED; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; ELDERLY CARE; ETHNICITY; FEMALE; FUNCTIONAL STATUS; HEART DISEASE; HIGH RISK POPULATION; HISPANIC; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SURVIVAL RATE; UNITED STATES;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHOLESTEROL; COHORT STUDIES; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GERIATRIC ASSESSMENT; HISPANIC AMERICANS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; NEW YORK CITY; PROBABILITY; PROPORTIONAL HAZARDS MODELS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; URBAN POPULATION;

EID: 41249098447     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afn017     Document Type: Article

References (33)

1. Stamler J, Stamler R, Neaton JD et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: Findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999; 282: 2012-8.
2. Fried LP, Kronmal RA, Newmann AB et al. Risk factors for 5-year mortality in older adults: The Cardiovascular Health Study. JAMA 1998; 279: 585-92.
3. Krumholtz HM, Seeman TE, Merrill SS et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA 1994; 272: 1335-40.
4. Benfante R, Reed D. Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA 1990; 263: 393-6.
5. Frost PH, Davis BR, Burlando AJ et al. Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP). Circulation 1996; 94: 2381-8.
6. Manolio TA, Ettinger WH, Tracy RP et al. The Cardiovascular Health Study. Epidemiology of low cholesterol levels in older adults. Circulation 1993; 87: 728-37.
7. Onder G, Landi F, Volpato S et al. Serum cholesterol levels and in-hospital mortality in the elderly. Am J Med 2003; 115: 265-71.
8. Schupf N, Costa R, Luchsinger J et al. Relationship between plasma lipids and all-cause mortality in nondemented elderly. J Am Geriatr Soc 2005; 53: 219-26.
9. Ked JE, Sutherland SE, Knapp RG et al. Does equal socioeconomic status in black and white men mean equal risk of mortality? Am J Public Health 1992; 82: 1133-6.
10. White AD, Hames CG, Tyroler HA. Serum cholesterol and 20-year mortality in black and white men and women aged 65 and older in the Evans County Heart Study. Ann Epidemiol 1992; 2: 85-91.
11. Jackson SA, Burke GL, Thach C et al. Incidence and predictors of coronary heart disease among older African Americans - the Cardiovascular Health Study. J Natl Med Assoc 2001; 93: 423-9.
12. Liao Y, Cooper RS, Cao G et al. Mortality from coronary heart disease and cardiovascular disease among adult U.S. Hispanics: Findings from the National Health Interview Survey (1986 to 1994). J Am Coll Cardiol 1997; 30: 1200-5.
13. Sorlie PD, Backlund E, Johnson NJ et al. Mortality by Hispanic status in the United States. JAMA 1993; 270: 2464-8.
14. Swenson CJ, Trepka MJ, Rewers MJ et al. Cardiovascular disease mortality in Hispanics and non-Hispanic whites. Am J Epidemiol 2002; 156: 919-28.
15. Hunt KJ, Resendez RG, Williams K et al. All-cause and cardiovascular mortality among Mexican-American and non-Hispanic White older participants in the San Antonio Heart Study- evidence against the "Hispanic paradox". Am J Epidemiol 2003; 158: 1048-57.
16. Mitchell BD, Haffner SM, Hazuda HP et al. Diabetes and coronary heart disease risk in Mexican Americans. Ann Epidemiol 1992; 2: 101-6.
17. Tang MX, Cross P, Andrews H et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 2001; 56: 49-56.
18. Census of Population and Housing Summary Tape File1. Technical Documentation. Washington, DC: Bureau of the Census, 1991.
19. Stem Y, Andrews H, Pittman J et al. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol 1992; 49: 453-60.
20. Association AP. Diagnostic and Statistical of Manual Disorders, 3rd edition. Washington, DC: American Psychiatric Association, 1987, Revised.
21. Hatano S. Experience from a multicenter stroke register: A preliminary report. Bull World Health Organ 1976; 54: 541-53.
22. Luchsinger JA, Reitz C, Honig LS et al. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 2005; 65: 545-51.
23. Lopez-Virella MF, Stone P, Ellis S et al. Cholesterol determination in high-density lipoproteiris separated by three different methods. Clin Chem 1977; 23: 882-4.
24. Friedewald WT, Levy RI, Fredickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
25. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-8.
26. Keil JE, Sutherland SE, Hames CG et al. Coronary disease mortality and risk factors in black and white men. Results from the combined Charleston, SC, and Evans County, Georgia, heart studies. Arch Intern Med 1995; 155: 1521-7.
27. Nietert PJ, Sutherland SE, Keil JE et al. Demographic and biologic influences on survival in whites and blacks: 40 years of follow-up in the Charleston heart study. Int J Equity Health 2006; 5: 8.
28. Palloni A, Arias E. Paradox lost: Explaining the Hispanic adult mortality advantage. Demograpby 2004; 41: 385-415.
29. Boyle CA, Decoufle P. National sources of vital status information: extent of coverage and possible selectivity in reporting. Am J Epidemiol 1990; 131: 160-8.
30. Stern MP, Wei M. Do Mexican Americans really have low rates of cardiovascular disease? Prev Med 1999; 29: S90-5.
31. McKeigue P. Ethnic variation in insulin resistance and risk of type 2 diabetes. In: Reaven G, Laws A, eds. Insulin Resistance: The Metabolic Syndrome X. Totowa, NJ: Humana Press, 1999; 19-34.
32. National Vital Statistics Report 2004; 53: 33-4 http://www.cdc.gov/nchs/ data/nvsr/nvsr53/nvsr53_06.pdf.
33. Reitz C, Tang MX, Luchsinger J et al. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 2004; 61: 705-14.